Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UX003 in Mucopolysaccharidosis Type 7
NCT01856218Phase 2Completed
- Sponsor
- Ultragenyx Pharmaceutical Inc.
- Start
- Nov 2013
- Primary completion
- Jul 2016
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of vestronidase alfa in mucopolysaccharidosis type VII, sponsored by Ultragenyx Pharmaceutical Inc.. Started Nov 2013; status: completed.
02
Drugs
vestronidase alfa
03
Conditions
mucopolysaccharidosis type VII
Beyond the preview
Go deeper on NCT01856218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01856218.